Peginterferon alpha-based therapy for chronic hepatitis B focusing on HBsAg clearance or seroconversion: a meta-analysis of controlled clinical trials.
about
Current and future directions for treating hepatitis B virus infectionChronic hepatitis B in 2014: great therapeutic progress, large diagnostic deficit.Mutations of pre-core and basal core promoter before and after hepatitis B e antigen seroconversionCONSORT: Effects of adding adefovirdipivoxil to peginterferon alfa-2a at different time points on HBeAg-positivepatients: A prospective, randomized study.Antiviral treatment to prevent chronic hepatitis B or C-related hepatocellular carcinoma.Standard and pegylated interferon therapy of HDV infection: A systematic review and meta- analysis.Hepatitis B virus surface antigen seroconversion in HIV-infected individual after pegylated interferon-alpha treatment: a case report.Persistent Loss of Hepatitis B Virus Markers in Serum without Cellular Immunity by Combination of Peginterferon and Entecavir Therapy in Humanized Mice.Combination therapy with pegylated interferon alpha-2b and adefovir dipivoxil in HBeAg-positive chronic hepatitis B versus interferon alone: a prospective, randomized study.Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumarate.Relationship between adhesion molecules and virological response to pegylated interferon-alpha-2a treatment in patients with chronic hepatitis B: A pilot study.Sustained efficacy of adefovir add-on therapy in chronic hepatitis B patient with a poor virological response to peginterferon alfa.Influence of Vitamin D Receptor Gene Polymorphisms on Response to Pegylated Interferon in Chronic Hepatitis B Egyptian Patients.
P2860
Q26851240-CADF8BB6-AD9C-472F-8A51-D0076132881EQ34137291-28DE9526-4984-4296-B25D-CAC249A31799Q34932600-370DEE43-8ACC-4AB9-90A8-27F4CC011B01Q37165176-8126B439-81D1-4C79-999A-E55DF88E0E1AQ37195548-B97D8F36-22CC-4145-9D6B-9BBAA32D3D74Q38119225-011F69A9-CEC5-4772-B961-2709A96AEED2Q39842524-565529F5-D097-4128-A2AF-B5F70A938D15Q40127647-07431CA7-3280-4897-8B0E-FDAF4EABBDF9Q42201316-FBEDBBEC-7445-43C3-850D-0C2AEDC357EEQ42204755-E7713BD3-EEF8-4BE2-A6F8-8F61CA67A4E3Q42244578-51AA42A9-58FD-471E-BDF0-75D322EE1D03Q43937621-97C97546-DDFF-420F-8C57-9C7A804AFB4BQ55295949-402237E5-D2DC-445F-8FFF-4977558AB24A
P2860
Peginterferon alpha-based therapy for chronic hepatitis B focusing on HBsAg clearance or seroconversion: a meta-analysis of controlled clinical trials.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Peginterferon alpha-based ther ...... of controlled clinical trials.
@ast
Peginterferon alpha-based ther ...... of controlled clinical trials.
@en
type
label
Peginterferon alpha-based ther ...... of controlled clinical trials.
@ast
Peginterferon alpha-based ther ...... of controlled clinical trials.
@en
prefLabel
Peginterferon alpha-based ther ...... of controlled clinical trials.
@ast
Peginterferon alpha-based ther ...... of controlled clinical trials.
@en
P2093
P2860
P356
P1476
Peginterferon alpha-based ther ...... of controlled clinical trials.
@en
P2093
Ling-Bo Kong
Mao-Rong Wang
Wei-Guang Ren
Wen-Cong Li
Yu-Guo Zhang
Yue-Min Nan
P2860
P2888
P356
10.1186/1471-2334-11-165
P577
2011-06-09T00:00:00Z
P5875
P6179
1034849611